CME Group Inc. (NASDAQ:CME – Get Free Report) COO Suzanne Sprague sold 1,500 shares of the firm’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at $2,063,885.88. This trade represents a 15.73 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
CME Group Trading Up 1.0 %
CME opened at $254.48 on Thursday. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock’s 50 day moving average price is $239.35 and its 200-day moving average price is $230.06. CME Group Inc. has a one year low of $190.70 and a one year high of $258.78. The stock has a market cap of $91.70 billion, a price-to-earnings ratio of 26.32, a P/E/G ratio of 6.76 and a beta of 0.57.
CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Increases Dividend
CME Group announced that its Board of Directors has authorized a stock buyback program on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 3.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s management believes its shares are undervalued.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the stock. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research note on Friday, February 14th. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Deutsche Bank Aktiengesellschaft cut their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Morgan Stanley boosted their price objective on CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 19th. Finally, Barclays increased their target price on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 13th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $236.13.
Get Our Latest Stock Analysis on CME
Hedge Funds Weigh In On CME Group
Institutional investors have recently made changes to their positions in the company. SJS Investment Consulting Inc. grew its holdings in CME Group by 570.6% during the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares in the last quarter. Truvestments Capital LLC purchased a new stake in CME Group during the third quarter worth $26,000. Dunhill Financial LLC lifted its holdings in CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock worth $27,000 after buying an additional 81 shares during the period. New Age Alpha Advisors LLC boosted its position in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after acquiring an additional 43 shares in the last quarter. Finally, Financial Life Planners bought a new position in shares of CME Group in the 4th quarter worth $32,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
- Five stocks we like better than CME Group
- Investing in Construction Stocks
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- The 3 Best Retail Stocks to Shop for in August
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.